desipramine has been researched along with Cancer of Liver in 3 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we investigated the effects of fluoxetine, desipramine, and mirtazapine on the liver metastasis of murine C26 colon carcinoma (cc)." | 8.31 | Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines. ( Arteta, B; Curzytek, K; Grygier, B; Kubera, M; Maes, M; Malicki, S, 2023) |
| " However, anti-proliferative effects of desipramine, a tricyclic antidepressant, in hepatocellular carcinoma are currently unknown." | 7.85 | Desipramine induces apoptosis in hepatocellular carcinoma cells. ( Kim, SJ; Yang, DK, 2017) |
| " In this study, we investigated the effects of fluoxetine, desipramine, and mirtazapine on the liver metastasis of murine C26 colon carcinoma (cc)." | 4.31 | Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines. ( Arteta, B; Curzytek, K; Grygier, B; Kubera, M; Maes, M; Malicki, S, 2023) |
| " However, anti-proliferative effects of desipramine, a tricyclic antidepressant, in hepatocellular carcinoma are currently unknown." | 3.85 | Desipramine induces apoptosis in hepatocellular carcinoma cells. ( Kim, SJ; Yang, DK, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kubera, M | 1 |
| Arteta, B | 1 |
| Grygier, B | 1 |
| Curzytek, K | 1 |
| Malicki, S | 1 |
| Maes, M | 1 |
| Yang, DK | 1 |
| Kim, SJ | 1 |
| Cai, W | 1 |
| Khaoustov, VI | 1 |
| Xie, Q | 1 |
| Pan, T | 1 |
| Le, W | 1 |
| Yoffe, B | 1 |
3 other studies available for desipramine and Cancer of Liver
| Article | Year |
|---|---|
Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines.
Topics: Animals; Antidepressive Agents; Carcinoma; Colonic Neoplasms; Cytokines; Desipramine; Fluoxetine; Li | 2023 |
Desipramine induces apoptosis in hepatocellular carcinoma cells.
Topics: Antidepressive Agents, Tricyclic; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Desipram | 2017 |
Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antiviral Agents; Cell C | 2005 |